Search details
1.
Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
J Pediatr
; 164(6): 1409-15.e4, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24657122
2.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
J Infect Dis
; 208(4): 544-53, 2013 Aug 15.
Article
in English
| MEDLINE | ID: mdl-23847058
3.
Safety and tolerability of zoster vaccine in adults ≥60 years old.
Hum Vaccin
; 7(11): 1130-6, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-22048110
4.
Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
Clin Infect Dis
; 49(1): e1-10, 2009 Jul 01.
Article
in English
| MEDLINE | ID: mdl-19476428
5.
A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents.
Pediatr Infect Dis J
; 28(2): 86-91, 2009 Feb.
Article
in English
| MEDLINE | ID: mdl-19116603
6.
A double-blind, randomized, controlled, multi-center safety and immunogenicity study of a refrigerator-stable formulation of VARIVAX®.
Vaccine
; 37(38): 5788-5795, 2019 09 10.
Article
in English
| MEDLINE | ID: mdl-30146405
7.
Characteristics of an ideal rotavirus vaccine.
Clin Pediatr (Phila)
; 47(6): 555-63, 2008 Jul.
Article
in English
| MEDLINE | ID: mdl-18467670
8.
Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.
Pediatr Infect Dis J
; 26(3): 201-9, 2007 Mar.
Article
in English
| MEDLINE | ID: mdl-17484215
9.
Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Int J Infect Dis
; 11 Suppl 2: S26-8, 2007 Nov.
Article
in English
| MEDLINE | ID: mdl-18162242
10.
Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
Pediatr Infect Dis J
; 25(10): 912-9, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-17006287
11.
Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Pediatr Infect Dis J
; 25(4): 287-92, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16567978
12.
Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
Pediatr Infect Dis J
; 24(8): 665-9, 2005 Aug.
Article
in English
| MEDLINE | ID: mdl-16094217
13.
Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
Pediatr Infect Dis J
; 24(8): 670-5, 2005 Aug.
Article
in English
| MEDLINE | ID: mdl-16094218
14.
M-M-R(®)II manufactured using recombinant human albumin (rHA) and M-M-R(®)II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.
Vaccine
; 33(18): 2132-40, 2015 Apr 27.
Article
in English
| MEDLINE | ID: mdl-25796337
15.
Measuring antibody responses to a live attenuated influenza vaccine in children.
Pediatr Infect Dis J
; 23(9): 852-6, 2004 Sep.
Article
in English
| MEDLINE | ID: mdl-15361726
16.
Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity.
Pediatr Infect Dis J
; 23(3): 240-5, 2004 Mar.
Article
in English
| MEDLINE | ID: mdl-15014300
17.
Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Pediatr Infect Dis J
; 23(2): 132-7, 2004 Feb.
Article
in English
| MEDLINE | ID: mdl-14872179
18.
Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pediatr Infect Dis J
; 21(9): 854-9, 2002 Sep.
Article
in English
| MEDLINE | ID: mdl-12352809
19.
Effect of influenza treatment with oseltamivir on health outcome and costs in otherwise healthy children.
Clin Drug Investig
; 24(7): 395-407, 2004.
Article
in English
| MEDLINE | ID: mdl-17516726
20.
A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination.
Hum Vaccin Immunother
; 10(8): 2395-407, 2014.
Article
in English
| MEDLINE | ID: mdl-25424947